3 months ago
LLY
AnalystsEmily FieldEmily Field's Stock Forecasts
AnalystsEmily Field
Sectors:
Industries:
Analyst Ranking
Top 41%
#2190 out of 5346 analysts
Average Return
+8.59%
Win Rate
67%6 out of 9
Risk vs Reward
Poor
Good
Emily Field's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Argenx SeARGX | +27.02% | $295.58 | $375.44 | 2021-10-19 - 2022-10-18 | Strong Buy |
Eli Lilly & CoLLY | +19.91% | $988.87 | $1,185.71 | 2026-05-05 - 2026-08-07 | Strong Buy |
Eli Lilly & CoLLY | +17.45% | $1,009.52 | $1,185.71 | 2026-02-20 - 2026-08-07 | Strong Buy |
Abbvie IncABBV | +9.44% | $224.81 | $246.04 | 2026-02-20 - 2026-08-07 | Strong Buy |
Bristol Myers Squibb CoBMY | +6.69% | $60.66 | $64.72 | 2026-02-20 - 2026-08-07 | Strong Buy |
Emily Field Analyst Color
Get additional color on Emily Field's coverage of popular stocks
6 months ago
MRK
6 months ago
LLY
Emily Field's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Merck & Co IncMRK | 2 | Strong Buy | $150.00 | +16.66% | Maintains | 10 days ago |
Gilead Sciences IncGILD | 2 | Hold | $145.00 | +8.85% | Maintains | 10 days ago |
Biogen IncBIIB | 2 | Hold | $200.00 | -3.82% | Maintains | 10 days ago |
Amgen IncAMGN | 2 | Hold | $360.00 | -12.40% | Maintains | 10 days ago |
Abbvie IncABBV | 2 | Strong Buy | $300.00 | +21.93% | Maintains | 10 days ago |
Eli Lilly & CoLLY | 2 | Strong Buy | $1,400.00 | +18.07% | Maintains | 3 months ago |
Pfizer IncPFE | 1 | Strong Sell | $25.00 | -6.58% | Initiates Coverage On | 6 months ago |
Bristol Myers Squibb CoBMY | 1 | Strong Buy | $75.00 | +15.88% | Initiates Coverage On | 6 months ago |
Argenx SeARGX | 1 | Strong Buy | N/A | N/A | Upgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.